Clinical Trial Update: Liraglutide and Cardio-Metabolic Risk Markers

View source ↗

Summary

The clinical trial update reports that a study investigating liraglutide and cardio-metabolic risk markers in type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: University of Palermo | Conditions: Type-2 Diabetes | Status: COMPLETED